From: Italian observational study on HPV infection, E6, and p16 expression in men with penile cancer
OR (95% CI) | p value | |
---|---|---|
Age, years | 1.0 (0.9–1.1) | 0.99 |
Age ≥ 55 years | 0.2 (0.0–2.4) | 0.21 |
Married | 0.6 (0.1–6.0) | 0.68 |
Employed | 1.6 (0.2–10.8) | 0.63 |
Anatomic site, Penis | 0.3 (0.1–1-2.0) | 0.23 |
Squamous Cell Carcinoma | 0.8 (0.0–13.4) | 0.85 |
Well differentiated, n (%) | 0.2 (0.0–0.8) | 0.02 |
Moderately differentiated, n (%) | 2.8 (0.5–14.5) | 0.23 |
Poorly differentiated, n (%) | 6.8 (0.7–69.6) | 0.11 |
Histopathological grading 2–3 | 6.3 (1.3–30.0) | 0.02 |
HPV positivity, n (%) | 0.6 (0.1–2.7) | 0.46 |
HPV-16 | 1.0 (0.2–5.2) | 0.96 |
HPV-56 | 1.3 (0.1–22.9) | 0.85 |
HPV-35 | – | – |
p-16 immunohistochemistry positivity, n (%) | 1.0 (0.2–5.2) | 0.96 |